Stockreport

IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine… [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF Imunon, Inc. (NASDAQ:IMNN) is developing IMNN-101, which is a COVID-19 seasonal vaccine booster based on the company's PlaCCine technology. It is a DNA vaccine that add [Read more]